Homebiotech

biotech

Stay Connected
- Advertisement -spot_img
Latest Articles

Positive topline results from phase 2 recurrent ovarian cancer trial

OSE Immunotherapeutics SA has announced the release of the abstract selected for an oral presentation at the upcoming ASCO 2026 annual meeting, unveiling topline...